HDFC Pharma and Healthcare Fund Direct Growth
3Y Annualised
N/A
0.80% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
8.27%
0.80% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
2 years 10 months
4 years 10 months
9 years 7 months
Fund info
Fund size
₹1786.18 Cr
Min. SIP amount
₹100
Min. Lumpsum amount
₹100
Exit load
0%
In respect of eachpurchase/switch-in ofunits, an Exit load of1% is payable if unitsare redeemed/switched-out within 30days from the date ofallotment. No Exit Load ispayable if units areredeemed / switchedout after 30 days fromthe date of allotment.
Risk Profile
Very High Risk
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
HDFC Pharma and Healthcare Fund Direct Growth
2nd
HDFC Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
3rd
HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
4th
HDFC Pharma and Healthcare Fund Regular Reinvestment Inc Dist cum Cap Wdrl
5th
HDFC Pharma and Healthcare Fund Regular Payout Inc Dist cum Cap Wdrl
Fund Managers
About HDFC Pharma and Healthcare Fund Direct Growth
HDFC Pharma and Healthcare Fund Direct Growth is a Equity mutual fund scheme from HDFC Asset Management Co Ltd. This fund has been in existence for 1 years, having been launched on 2023-10-04. HDFC Pharma and Healthcare Fund Direct Growth has ₹1786.18 Cr worth of assets under management (AUM) as of Fri Jul 25 2025. The latest Net Asset Value (NAV) of HDFC Pharma and Healthcare Fund Direct Growth as of Thu Jul 24 2025 is ₹18.065. The fund has an expense ratio of 0.86%, which is medium comparable to most other Equity funds.
HDFC Pharma and Healthcare Fund Direct Growth returns for the last 1 year are 27.70%. Since launch, it has delivered 39.06% average annual returns.
The HDFC Pharma and Healthcare Fund Direct Growth has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of HDFC Pharma and Healthcare Fund Direct Growth.
- Sun Pharmaceuticals Industries Ltd: 11.68%
- Divi's Laboratories Ltd: 10.06%
- Cipla Ltd: 6.87%
- Lupin Ltd: 5.60%
- Glenmark Pharmaceuticals Ltd: 5.53%
AMC Information
| Name | HDFC Asset Management Co Ltd |
|---|---|
| Founding Date | 2023-10-04 |
| cliser@hdfcfund.com | |
| Phone | +91 22 66316333 |
| Website | www.hdfcfund.com |
| Address | HDFC Asset Management Company Limited,“HUL House”, 2nd Floor,,H.T. Parekh Marg,165-166, Backbay Reclamation,,Churchgate, |
Tax Implications of HDFC Pharma and Healthcare Fund Direct Growth
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from HDFC Asset Management Co Ltd
AlternativeArbitrage Fund
3Y CAGR
6.97%
expense ratio
0.94%
fund size
₹21068.10 Cr
Fixed IncomeGovernment Bond
3Y CAGR
7.94%
expense ratio
0.89%
fund size
₹3029.51 Cr
Fixed IncomeMedium to Long Duration
3Y CAGR
7.70%
expense ratio
1.39%
fund size
₹956.42 Cr
EquityEquity - Infrastructure
3Y CAGR
33.41%
expense ratio
1.06%
fund size
₹2591.14 Cr
AllocationFund of Funds
3Y CAGR
13.97%
expense ratio
0.42%
fund size
₹1192.68 Cr
FAQs
What is the current NAV of HDFC Pharma and Healthcare Fund Direct Growth?
What are the average returns of HDFC Pharma and Healthcare Fund Direct Growth?
How do I invest in HDFC Pharma and Healthcare Fund Direct Growth?
What is the expense ratio of HDFC Pharma and Healthcare Fund Direct Growth?
What are net assets under management (AUM) of HDFC Pharma and Healthcare Fund Direct Growth?
What is the PE and PB ratio of HDFC Pharma and Healthcare Fund Direct Growth?
What are the top 5 holdings of HDFC Pharma and Healthcare Fund Direct Growth?
What are the top 3 sectors that HDFC Pharma and Healthcare Fund Direct Growth has invested in?
Who is the manager of HDFC Pharma and Healthcare Fund Direct Growth?
What is the exit load of HDFC Pharma and Healthcare Fund Direct Growth?
How to Redeem HDFC Pharma and Healthcare Fund Direct Growth?
Can I invest in SIP and a Lump Sum of HDFC Pharma and Healthcare Fund Direct Growth?
